secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENXBIO Inc. (RGNX)
CIK:        0001590877
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0000950170-25-080986
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

REGENXBIO stockholders elect four Class I directors, approve 2025 equity plan
-----------------------------------------------------------------------------

- Four Class I directors elected: Fox (27.99M for), Glucksmann (29.26M), Simpson (32.80M), Zachary (29.18M) until 2028.
- Ratified PricewaterhouseCoopers as independent auditor for FY2025: 41.17M for, 39,375 against.
- Advisory approval of named executive officer compensation: 32.58M for, 1.76M against.
- Advisory vote on frequency: 'Every 1 Year' received 33.15M votes; company will hold annual say-on-pay votes.
- Approved 2025 Equity Incentive Plan: 27.40M for, 6.97M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590877/000095017025080986/0000950170-25-080986-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590877/000095017025080986/rgnx-20250530.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-080986

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer